Real-time enrollment status for this alpha 1 antitrypsin deficiency clinical trial
Current Status
Recruiting
Checked: July 13, 2026 at 6:38 AM UTC
| NCT Number | NCT07555483 |
| Recruiting Status | Recruiting |
| Condition | Alpha 1 Antitrypsin Deficiency |
| Phase | Clinical Trial |
| Target Enrollment | 40 participants |
| Active Locations | 10 sites in the US |
| Sponsor | Grifols Therapeutics LLC |
| Last Updated on CT.gov | June 1, 2026 (Jun 1, 2026) |
As of July 13, 2026: Clinical trial NCT07555483 is currently recruiting participants. This clinical trial study for alpha 1 antitrypsin deficiency is actively seeking new participants at 10 locations across the United States. The study is sponsored by Grifols Therapeutics LLC. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07555483 is actively recruiting participants as of July 13, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 10 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07555483 was last updated Jun 1, 2026 (June 1, 2026). HelloStudys verifies this status automatically.